chr4-54285791-T-TA
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_006206.6(PDGFRA):c.2440-50_2440-49insA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.831 in 1,600,954 control chromosomes in the GnomAD database, including 558,022 homozygotes. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.76 ( 45100 hom., cov: 0)
Exomes 𝑓: 0.84 ( 512922 hom. )
Consequence
PDGFRA
NM_006206.6 intron
NM_006206.6 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.30
Genes affected
PDGFRA (HGNC:8803): (platelet derived growth factor receptor alpha) This gene encodes a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer or a heterodimer, composed of both platelet-derived growth factor receptor alpha and beta polypeptides. Studies suggest that this gene plays a role in organ development, wound healing, and tumor progression. Mutations in this gene have been associated with idiopathic hypereosinophilic syndrome, somatic and familial gastrointestinal stromal tumors, and a variety of other cancers. [provided by RefSeq, Mar 2012]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 4-54285791-T-TA is Benign according to our data. Variant chr4-54285791-T-TA is described in ClinVar as [Benign]. Clinvar id is 873180.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.85 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDGFRA | ENST00000257290.10 | c.2440-50_2440-49insA | intron_variant | Intron 17 of 22 | 1 | NM_006206.6 | ENSP00000257290.5 | |||
ENSG00000282278 | ENST00000507166.5 | c.1720-50_1720-49insA | intron_variant | Intron 18 of 23 | 2 | ENSP00000423325.1 |
Frequencies
GnomAD3 genomes AF: 0.757 AC: 114952AN: 151914Hom.: 45087 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
114952
AN:
151914
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.805 AC: 201018AN: 249854 AF XY: 0.814 show subpopulations
GnomAD2 exomes
AF:
AC:
201018
AN:
249854
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.839 AC: 1215338AN: 1448922Hom.: 512922 Cov.: 31 AF XY: 0.840 AC XY: 606287AN XY: 721696 show subpopulations
GnomAD4 exome
AF:
AC:
1215338
AN:
1448922
Hom.:
Cov.:
31
AF XY:
AC XY:
606287
AN XY:
721696
Gnomad4 AFR exome
AF:
AC:
17448
AN:
33282
Gnomad4 AMR exome
AF:
AC:
30676
AN:
44706
Gnomad4 ASJ exome
AF:
AC:
23972
AN:
26036
Gnomad4 EAS exome
AF:
AC:
33801
AN:
39638
Gnomad4 SAS exome
AF:
AC:
67491
AN:
86004
Gnomad4 FIN exome
AF:
AC:
45567
AN:
52084
Gnomad4 NFE exome
AF:
AC:
941374
AN:
1101658
Gnomad4 Remaining exome
AF:
AC:
50070
AN:
59944
Heterozygous variant carriers
0
10556
21112
31669
42225
52781
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
20836
41672
62508
83344
104180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.756 AC: 115005AN: 152032Hom.: 45100 Cov.: 0 AF XY: 0.758 AC XY: 56361AN XY: 74310 show subpopulations
GnomAD4 genome
AF:
AC:
115005
AN:
152032
Hom.:
Cov.:
0
AF XY:
AC XY:
56361
AN XY:
74310
Gnomad4 AFR
AF:
AC:
0.534366
AN:
0.534366
Gnomad4 AMR
AF:
AC:
0.747285
AN:
0.747285
Gnomad4 ASJ
AF:
AC:
0.930796
AN:
0.930796
Gnomad4 EAS
AF:
AC:
0.850853
AN:
0.850853
Gnomad4 SAS
AF:
AC:
0.763191
AN:
0.763191
Gnomad4 FIN
AF:
AC:
0.869832
AN:
0.869832
Gnomad4 NFE
AF:
AC:
0.85609
AN:
0.85609
Gnomad4 OTH
AF:
AC:
0.801519
AN:
0.801519
Heterozygous variant carriers
0
1275
2551
3826
5102
6377
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
848
1696
2544
3392
4240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2653
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Squamous cell lung carcinoma Uncertain:1
May 05, 2020
Faculté Pluridciplinaire Nador, Université Mohamed Premier
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing;in vivo
- -
not provided Benign:1
Jun 22, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mutation Taster
=31/69
disease causing
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at